Dacryoendoscopic recanalization of lacrimal passage obstruction/stenosis after radioiodine therapy for differentiated thyroid carcinoma.
Dacryoendoscopy
Nasolacrimal duct obstruction
Radioiodine therapy
Journal
American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
01
07
2021
accepted:
22
01
2022
entrez:
4
3
2022
pubmed:
5
3
2022
medline:
5
3
2022
Statut:
epublish
Résumé
Radioiodine therapy, a standard treatment for differentiated thyroid carcinomas, is associated with several adverse events including lacrimal drainage system obstruction. Herein, we describe the first case of duct lumen recanalization using dacryoendoscopy for lacrimal passage obstruction and stenosis after radioiodine therapy. A 48-year-old female treated with radioiodine therapy for differentiated thyroid carcinoma 5 years prior presented with epiphora in both eyes. Dacryocystography showed nasolacrimal duct stenosis in the right eye and nasolacrimal duct obstruction in the left eye. Dacryoendoscopic examination revealed right common canalicular polyps, fibrosis in the right lacrimal sac, right nasolacrimal duct stenosis, and left upper and common canaliculus stenosis. Lacrimal passage recanalization with the insertion of a nasolacrimal stent tube using dacryoendoscopy was performed on the right eye. This successfully resolved the epiphora. Dacryoendoscopic examination for epiphora after radioiodine therapy may help detect early-stage nasolacrimal passage obstruction/stenosis. This condition can be resolved by recanalization and insertion of a lacrimal tube, without the need for a more invasive surgical approach such as dacryocystorhinostomy.
Identifiants
pubmed: 35243134
doi: 10.1016/j.ajoc.2022.101344
pii: S2451-9936(22)00090-1
pmc: PMC8859738
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101344Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
None.
Références
JAMA. 2006 May 10;295(18):2164-7
pubmed: 16684987
J Clin Med. 2020 Aug 26;9(9):
pubmed: 32858911
Clin Ophthalmol. 2014 Dec 05;8:2479-84
pubmed: 25525325
Ophthalmic Plast Reconstr Surg. 2019 Nov/Dec;35(6):519-524
pubmed: 31162301
Ophthalmic Plast Reconstr Surg. 2016 Jul-Aug;32(4):243-8
pubmed: 26866333
Ophthalmic Plast Reconstr Surg. 2004 Mar;20(2):126-9
pubmed: 15083081
J Clin Endocrinol Metab. 1992 Sep;75(3):714-20
pubmed: 1517360
Thyroid. 2013 Feb;23(2):243-5
pubmed: 22946448
PLoS One. 2020 May 19;15(5):e0233295
pubmed: 32428008
Am J Ophthalmol. 2011 Jul;152(1):147-150.e2
pubmed: 21570053
Thyroid. 2016 Dec;26(12):1761-1767
pubmed: 27565021